Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,244 public trials 1,186 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung

NCT01561456

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +17 more
Locations
  • State Medical Institution: Republic Scientific Oncology Center Poselok, Minsk Oblast, Belarus
  • Gomel Regional Clinical Oncology Center Homyel, Belarus
  • Minsk City Clinical Oncology Center Minsk, Belarus
  • Vitebsk Regional Clinical Oncology Center Vitebsk, Belarus
View all 24 locations
View Trial Details
Completed

A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer

NCT00349492

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Soonchunhyang University Bucheon Hospital Bucheon-si, South Korea
  • Yeungnam University Hospital Daegu, South Korea
  • Daegu Catholic University Hospital Daegu, South Korea
  • Gyeongsang National University Hospital Jinju, South Korea
View all 14 locations
View Trial Details
Completed

S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors

NCT00062439

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Poudre Valley Hospital Fort Collins, Colorado, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Rush-Copley Cancer Care Center Aurora, Illinois, United States
View all 154 locations
View Trial Details
Completed

Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

NCT00002577

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Huntsville Hospital System Huntsville, Alabama, United States
  • Comprehensive Cancer Institute of Huntsville Huntsville, Alabama, United States
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
View all 242 locations
View Trial Details
Completed

A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

NCT00600821

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +12 more
Locations
  • Pfizer Investigational Site Baton Rouge, Louisiana, United States
  • Pfizer Investigational Site Pittsfield, Massachusetts, United States
  • Pfizer Investigational Site Columbus, Mississippi, United States
  • Pfizer Investigational Site Corinth, Mississippi, United States
View all 44 locations
View Trial Details

Related conditions